News | September 16, 2008

ACC Launches Healthcare Reform Campaign

September, 17, 2008 - The American College of Cardiology (ACC) yesterday launched its Quality First campaign that advocates for new standards for quality in healthcare reform, while setting forth initiatives to begin moving the American healthcare system immediately and dramatically forward.
The ACC released findings from a recent survey revealing the American public's dissatisfaction with the current healthcare system and the need for doctors, especially cardiologists, to be involved in the reform movement. While 52 percent of Americans feel that the costs of healthcare are too high, 77 percent are also unhappy with the way the healthcare system is being regulated.
"The results of the survey could not be clearer. Americans want healthcare reform now," said ACC CEO Jack Lewin, M.D. "The goal of the Quality First campaign is to advocate for the highest quality of care at the most effective cost. We are committed to working with payers, Congress and other organizations on pilot programs, legislation, strengthened quality measures, guidelines and appropriate use of technology."
Eighty-six percent of survey participants said that they would most trust doctors and medical or patient advocacy groups to set standards for measuring and reporting health care quality. Through the Quality First campaign, the ACC is committed to supporting efforts to increase transparency, focus on measurable outcomes and provide accountability in care, as well as advocate for the development and implementation of health information technology to increase the quality of care and help control costs.
According to the survey, 83 percent of Americans agree that the primary objectives of the ACC are extremely or very important and 64 percent said that the ACC's top priorities should be setting new standards for health care reform and advocating for sound healthcare priorities.
"Considering that heart disease is the leading killer in the U.S. and that more than 40 percent of Medicare spending goes towards cardiovascular-related medicine, cardiologists and the ACC are in a key position to refocus the healthcare debate and work with Congress and our partners on creating a new vision for healthcare," said ACC President W. Douglas Weaver, M.D. "Americans want their cardiologists involved in this vitally important process and through the Quality First campaign, the ACC is committing itself to ensuring that Americans get the healthcare they need and deserve."
The survey, conducted by Luntz, Maslansky Strategic Research, polled a nationally representative sample of 1,003 American likely voters with a margin of error of 3.1 percent.

For more information: www. acc.org

Related Content

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Interventional Radiology | April 03, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
COVID-19 outbreak in Seattle cancels SIR 2020 meeting. Interventional radiology meeting cancelled. #COVID19 #coronavirus #2019nCoV
News | Interventional Radiology | March 09, 2020 | Melinda Taschetta-Millane
March 9, 2020 — As the novel coronavirus (COVID-19) slowly spreads across the globe, more industry conferences are de
DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

DSA image obtained approximately 24 hours after 1 mg/h IA tPA infusion, 500 U/h heparin via peripheral IV, and daily oral aspirin (81 mg) shows improved perfusion of digital arteries, albeit with suboptimal vascular blush of distal second and third phalanges. Photo courtesy of ARRS

News | Interventional Radiology | February 11, 2020
February 11, 2020 — An ahead-of-print...
New SIR position statement and quality documents highlight interventional radiology effective use of nonsurgical ablation to treat kidney cancer in selected patients
News | Interventional Radiology | February 04, 2020
February 4, 2020 — For some patients, kidney cancer can be effectively treated without surgery, according to the Soci
Smart Speaker Technology Harnessed for Hospital Medical Treatments
News | Interventional Radiology | April 10, 2019
Smart speakers customarily used in your living room can act as an aid to physicians in hospital operating rooms,...
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...
Embolx Announces FDA Clearance of Next-generation Sniper Balloon Occlusion Microcatheter
Technology | Interventional Radiology | June 29, 2018
Embolx Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its next-generation...
Guerbet Launches Pair of Microcatheters for Interventional Radiology Procedures
Technology | Interventional Radiology | May 23, 2018
Guerbet LLC USA announced the upcoming launch of SeQure and DraKon, two novel microcatheters for tumor and vascular...
U.S. First Lady Melania Trump Undergoes Interventional Radiology Embolization Procedure
News | Interventional Radiology | May 15, 2018
U.S. First Lady Melania Trump underwent an interventional radiology embolization procedure to treat a benign kidney...